TY - JOUR
T1 - The Pros and Cons of Mendelian Randomization Studies to Evaluate Emerging Cardiovascular Risk Factors
AU - Savla, Jainy
AU - Neeland, Ian J.
N1 - Funding Information:
Conflict of Interest Dr. Neeland reports personal fees from Boehringer-Ingelheim, American Heart Association, and from Advanced MR Analytics AB, plus grants from Novo Nordisk. Dr. Savla has nothing to declare.
Funding Information:
Funding Dr. Neeland is supported by grant K23DK106520 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institute of Health and by the Dedman Family Scholarship in Clinical Care from UT Southwestern.
Publisher Copyright:
© 2018, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Purpose of Review: Mendelian randomization (MR) is a technique that uses natural genetic variation to assess the potential causal role of a modifiable risk factor on cardiovascular disease. Advances have led to the identification of single nucleotide polymorphisms linked with risk factors that act as naturally randomized instruments to investigate the risk factor-disease relationship. Recent Findings: There are several pros and cons when using MR. It can address many limitations of observational study design including confounding, reverse causation, and demonstration of causality when a randomized controlled trial is not practical or feasible. However, several limitations do exist and include pleiotropy (multiple downstream effects of a single genetic variant), linkage disequilibrium (non-random association of genetic variation), and imprecise estimates of causal effects. Summary: MR is an important tool in cardiovascular research and has been applied to assess cardiovascular risk factors including obesity and atrial fibrillation. While these studies provide insight into disease causation, understanding the strengths and limitations of the technique is important for appropriate interpretation of results.
AB - Purpose of Review: Mendelian randomization (MR) is a technique that uses natural genetic variation to assess the potential causal role of a modifiable risk factor on cardiovascular disease. Advances have led to the identification of single nucleotide polymorphisms linked with risk factors that act as naturally randomized instruments to investigate the risk factor-disease relationship. Recent Findings: There are several pros and cons when using MR. It can address many limitations of observational study design including confounding, reverse causation, and demonstration of causality when a randomized controlled trial is not practical or feasible. However, several limitations do exist and include pleiotropy (multiple downstream effects of a single genetic variant), linkage disequilibrium (non-random association of genetic variation), and imprecise estimates of causal effects. Summary: MR is an important tool in cardiovascular research and has been applied to assess cardiovascular risk factors including obesity and atrial fibrillation. While these studies provide insight into disease causation, understanding the strengths and limitations of the technique is important for appropriate interpretation of results.
KW - Cardiovascular disease
KW - Cardiovascular risk factors
KW - Genetic variants
KW - Mendelian randomization
KW - Observational study design
KW - Randomized controlled trials
UR - http://www.scopus.com/inward/record.url?scp=85040828018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85040828018&partnerID=8YFLogxK
U2 - 10.1007/s12170-018-0566-9
DO - 10.1007/s12170-018-0566-9
M3 - Review article
AN - SCOPUS:85040828018
SN - 1932-9520
VL - 12
JO - Current Cardiovascular Risk Reports
JF - Current Cardiovascular Risk Reports
IS - 1
M1 - 2
ER -